Cui Rosa, Fayek Sameh, Rand Elizabeth B, Feygin Tamara, Khrichenko Dmitry, Shaked Abraham
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Pediatr Transplant. 2012 Sep;16(6):E251-6. doi: 10.1111/j.1399-3046.2011.01591.x. Epub 2011 Oct 24.
An 11-yr-old child presented with acute mental status changes and spastic quadriplegia after orthotopic liver transplantation. Magnetic resonance (MR) imaging findings were consistent with central pontine and EPM. Initial immunosuppression included tacrolimus, mycophenolate mofetil, and corticosteroids. Given that neurotoxicity is a well-established side effect of CNI, the patient was converted to rapamycin and subsequently experienced significant neurologic recovery. The temporal resolution of the patient's symptoms suggests that prompt recognition of central pontine and EPM and conversion from tacrolimus to rapamycin during the early post-operative course may have therapeutic benefits for patients undergoing pediatric transplant with CNI-related neurotoxicity.
一名11岁儿童在原位肝移植后出现急性精神状态改变和痉挛性四肢瘫。磁共振成像结果与脑桥中央髓鞘溶解症和渗透性髓鞘溶解症相符。初始免疫抑制治疗包括他克莫司、霉酚酸酯和皮质类固醇。鉴于神经毒性是钙调神经磷酸酶抑制剂(CNI)公认的副作用,该患者改用雷帕霉素,随后神经功能有显著恢复。患者症状的时间演变表明,对于接受儿科移植且有CNI相关神经毒性的患者,在术后早期迅速识别脑桥中央髓鞘溶解症和渗透性髓鞘溶解症,并从他克莫司转换为雷帕霉素可能具有治疗益处。